Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease
Clinical trial NCT01226420 · TERMINATED
Trial details
- NCT number
- NCT01226420
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2012-08-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.